Digital transformation is no longer a buzzword, it’s a strategic imperative. How can life sciences companies advance their capabilities and take a more holistic view of their digital strategies?
Opportunities for digital transformation are available throughout the healthcare and life sciences industry, from improving finance, supply chain, and manufacturing operations, to developing new products and services, to engaging differently with customers and patients.
Disrupt existing processes and establish new opportunities with predictive manufacturing, Big Data and advanced analytics, and robotics. Digital transformation offers pharmaceutical and medical device companies the opportunities to execute efficiently, engage effectively, and innovate new products and services.
As your trusted partner and advisor in this journey, Columbus helps you evolve and transform digitally to become future ready.
The Life Sciences industry is unique in many ways, mainly because it “evolves” as companies go through the lifecycle from pre-clinical to market.
Each lifecycle phase has unique requirements, but often we come back to the same five key features that companies need to address with their business management and ERP solutions.
In a COVID-19 world, patient safety and innovation in medical device capabilities have become paramount to saving lives. In this context, the Unique Device Identification (UDI) System as a topic of discussion is garnering increasing attention.